Based upon physical examination, St, Jude Medical's analysis indicates the damage to the Durata lead is consistent with external abrasion from contact with a calcified, or hardened, heart valve or possibly from lead-to-lead contact

June 25, 2012 — The first 10 cardiac catheterization laboratories to undergo review by Accreditation for Cardiovascular Excellence (ACE) all welcomed the evaluation by outside experts. Still, review teams found insufficiencies in record-keeping and other quality metrics at well-run medical centers, according to two studies presented at the recent Society for Cardiovascular Angiography and Interventions (SCAI) 2012 Scientific Sessions.

June 25, 2012 — Among six large integrated healthcare systems between 1996 and 2010 there was a substantial increase in the use of advanced diagnostic imaging, according to a study in the Journal of the American Medical Association (JAMA).

June 22, 2012 — In a recently approved position statement, the American Association of Physicists in Medicine (AAPM) affirms that computed tomography (CT) scans are important diagnostic tools for children and adults when used appropriately.

June 22, 2012 — Vital Images Inc., a Toshiba Medical Systems Group company, has been recognized by J.D. Power and Associates for the third consecutive year.

June 22, 2012 — Siemens Healthcare has announced that the U.S. Food and Drug Administration (FDA) has cleared the Somatom Perspective, an advanced 128-slice computed tomography (CT) scanner engineered to drive efficiency and reduce costs.

June 22, 2012 — Philips introduced the iDose4 Premium Package, which includes two technologies that can improve image quality: the iDose4 iterative reconstruction technique, and metal artifact reduction for large orthopedic implants (O-MAR).

June 22, 2012 — The University of Miami Miller School of Medicine’s Interdisciplinary Stem Cell Institute (ISCI) announced that it received a $10 million grant from The Starr Foundation, one of the largest private foundations in the United States.

June 22, 2012 –– The U.S. Food and Drug Administration (FDA) recently selected a stent graft being developed by Medtronic Inc. for an early feasibility pilot program that allows for “early clinical evaluation to provide proof of principle and initial clinical safety data.”

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now